Differential human multiple myeloma cell line responsiveness to interferon-alpha. Analysis of transcription factor activation and interleukin 6 receptor expression
about
P1343
Physical and functional interactions between Daxx and STAT3A role for IFN-lambda1 in multiple myeloma B cell growthInterferon in the Treatment of Multiple Myeloma.Interferon and cytotoxic chemotherapy for the treatment of post-transplant lymphoproliferative disorder.Regulation of Bcl-2-family proteins in myeloma cells by three myeloma survival factors: interleukin-6, interferon-alpha and insulin-like growth factor 1.Genetic variations in multiple myeloma II: association with effect of treatment.IFNgamma sensitization to TRAIL-induced apoptosis in human thyroid carcinoma cells by upregulating Bak expression.A role for Janus kinases in crosstalk between ErbB3 and the interferon-alpha signaling complex in myeloma cells.Atypical expression of ErbB3 in myeloma cells: cross-talk between ErbB3 and the interferon-alpha signaling complex.Insulin-like growth factor induces the survival and proliferation of myeloma cells through an interleukin-6-independent transduction pathway.Telomerase activity in myeloma cells is closely related to cell cycle status, but not to apoptotic signals induced by interferon-alpha.Human myeloma cell apoptosis induced by interferon-alpha.Differential myeloma cell responsiveness to interferon-alpha correlates with differential induction of p19(INK4d) and cyclin D2 expression.Hyaluronic acid induces survival and proliferation of human myeloma cells through an interleukin-6-mediated pathway involving the phosphorylation of retinoblastoma protein.Phenotypic and Transcriptomic Analysis of Peripheral Blood Plasmacytoid and Conventional Dendritic Cells in Early Drug Naïve Rheumatoid Arthritis.
P2860
Q24298142-ACAC3DD2-F71D-41A6-B7CD-A830B06EB238Q24645649-27AAA0E8-7FF9-4442-92F2-CE08E33BA61DQ33889240-467EBC0A-7F47-4635-B15A-F64DF575C93BQ34275888-555BE190-E620-4475-8B59-71F19F67E722Q36711639-A0B98EC5-BF61-48B6-982D-E45B3DD4FAABQ37924890-22358F27-DF3A-46DA-8020-674B43EBE0C2Q40612594-C0CD96E5-8A0F-433B-9E22-E16D0C55E8E6Q40612605-922B1233-FA63-41DE-8EDD-A6412E748095Q40642077-B7B22204-E816-4387-91AF-A31E1ADAED50Q40836610-D70A3B3A-4306-45F2-A893-7159F99935D8Q40936707-7984A9E6-0893-4240-81A8-A7421AE05505Q40992802-7DEC211C-26ED-4FD4-8F15-BBD90F100CFCQ41035096-9A409F14-D487-405A-A241-9DA9B80799B5Q43559228-A5192945-70CB-45EA-B48D-66F70A7EA6A8Q55344794-64FF878C-2D2A-412B-A821-B9916EDBAF0A
P2860
Differential human multiple myeloma cell line responsiveness to interferon-alpha. Analysis of transcription factor activation and interleukin 6 receptor expression
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 1997
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Differential human multiple my ...... erleukin 6 receptor expression
@en
Differential human multiple my ...... rleukin 6 receptor expression.
@nl
type
label
Differential human multiple my ...... erleukin 6 receptor expression
@en
Differential human multiple my ...... rleukin 6 receptor expression.
@nl
prefLabel
Differential human multiple my ...... erleukin 6 receptor expression
@en
Differential human multiple my ...... rleukin 6 receptor expression.
@nl
P2093
P2860
P356
P1476
Differential human multiple my ...... erleukin 6 receptor expression
@en
P2093
B K Arendt
D F Jelinek
J J Westendorf
K M Aagaard-Tillery
R C Tschumper
P2860
P304
P356
10.1172/JCI119179
P407
P4510
P577
1997-02-01T00:00:00Z